Jung, S.-K.; Kim, Y.-M.; Jo, M.-J.; Son, J.-Y.; Ju, J.-S.; Park, M.-K.; Lee, M.-K.; Kim, J.-Y.; Nam, J.-S.; Ahn, D.-K.
Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain? Toxins 2025, 17, 130.
https://doi.org/10.3390/toxins17030130
AMA Style
Jung S-K, Kim Y-M, Jo M-J, Son J-Y, Ju J-S, Park M-K, Lee M-K, Kim J-Y, Nam J-S, Ahn D-K.
Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain? Toxins. 2025; 17(3):130.
https://doi.org/10.3390/toxins17030130
Chicago/Turabian Style
Jung, Sung-Koog, Yu-Mi Kim, Min-Jeong Jo, Jo-Young Son, Jin-Sook Ju, Min-Kyoung Park, Min-Kyung Lee, Jae-Young Kim, Jeong-Sun Nam, and Dong-Kuk Ahn.
2025. "Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain?" Toxins 17, no. 3: 130.
https://doi.org/10.3390/toxins17030130
APA Style
Jung, S.-K., Kim, Y.-M., Jo, M.-J., Son, J.-Y., Ju, J.-S., Park, M.-K., Lee, M.-K., Kim, J.-Y., Nam, J.-S., & Ahn, D.-K.
(2025). Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain? Toxins, 17(3), 130.
https://doi.org/10.3390/toxins17030130